CASP3 and glioblastoma: This level of caspase-3 activity is insufficient for the execution of apoptosis, but suggests PAC-1 may be particularly effective in activating this partially primed pool of procaspase-3/caspase-3, thereby providing the greatest therapeutic benefit to the invasive glioblastoma cells remaining after surgery.